SRRA... following reverse stock split... Gilead Sc
Post# of 144919
![](/assets/46931549/no_avatar_available_thumb.jpg)
PR: https://finance.yahoo.com/news/sierra-oncolog...00366.html
Gilead is getting into oncology. Can someone please elaborate on what SRRA has and comparison to CYDY.
I understand their product is second in line, for some cancers, and they are expecting Phase 3 data Q4 2021, and still a lot of uncertainties.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)